agilon health inc. (AGL)
NYSE: AGLHealth CareMisc Health and Biotechnology ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AGL stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.52B
- Forward P/E
- 20.70
- EPS (TTM)
- -$6.69
- Dividend yield
- None
- 52-week range
- 7.48 – 133.04
- Day range
- 85.77 – 90.27
- Volume / Avg
- 266.32K / 226.26K
- Beta
- —
- Shares outstanding
- 16.80M
52-week range
AGL stock today
On Nov 20, AGL ended the session at $90.24, adding $0.74 (0.83%), versus the S&P 500's 3.70% decline. At this level, AGL sits in the middle of its 52-week range of $7.48 to $133.04: 32.2% below the high, set on Jul 17, 2026 and 1106.4% above the low. AGL is up 423.9% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 481.3%.
agilon health inc. has posted a net loss over the last twelve months (EPS of -$6.69), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About agilon health inc.
Company profileagilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month.
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- CEO
- Mr. Timothy Patrick O'Rourke
- Headquarters
- Westerville, OH
- Employees
- 856
- IPO year
- 2021
- Website
- agilonhealth.com
Financial highlights
Full financialsIn fiscal 2025, agilon health inc. generated $5.93 billion in revenue, down 2.1% from fiscal 2024, the first decline in the 7 years shown. agilon health inc. reported a net loss of $391.3 million, compared with a loss of $260.2 million a year earlier. Operating margin was -7.8%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $5.93B | $6.06B | $4.32B | $2.39B | $1.52B |
| Growth | -2.11% | +40.41% | +80.74% | +56.97% | +24.88% |
| Net income | $-391.35M | $-260.15M | $-262.60M | $-106.55M | $-406.49M |
| EPS (diluted) | $-0.98 | $-0.61 | $-0.48 | $-0.22 | $-1.03 |
Analyst forecast
ForecastConsensus (15 analysts)
buy
Avg. price target
$124.83+38.33%
- Strong buy 0
- Buy 5
- Hold 9
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 4, 2026
- EPS actual vs est.
- $1.97 vs $-2.01
- Surprise
- +198.01%
AGL news
All AGL news- Best Momentum Stocks to Buy for November 19thNasdaqAGL, AIZ, KROS
- New Strong Buy Stocks for November 19thNasdaqAGL, AIZ, PANL, EQNR
- Notable Wednesday Option Activity: ASTS, AGL, TNETNasdaqASTS, AGL, TNET
- agilon health, inc. Presents Total Care Model and Clinical Pathways at November 17, 2026 Investor EventNasdaq
- Best Momentum Stocks to Buy for November 16thNasdaqAGL, PH, GMRS
- agilon health Consensus Price Target Raised 10.90% to $123.61Nasdaq
- agilon health, inc. Reports Third Quarter 2026 ResultsNasdaq
- agilon health Reports Third Quarter 2026 ResultsBusiness Wire
agilon health inc. peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PGNYProgyny Inc. | 35.71 | +0.73% | $2.63B | vs AGL |
| VMDViemed Healthcare Inc. | 8.52 | -1.05% | $322.85M | vs AGL |
| PARKPark Dental Partners Inc. | 17.03 | -6.79% | $94.26M | vs AGL |
| CCELCryo-Cell International Inc. | 4.15 | 0.00% | $33.46M | vs AGL |
| MGRXMangoceuticals Inc. | 0.1236 | -7.55% | $2.75M | vs AGL |
| NIVFNewGenIvf Group Limited Class A | 0.0269 | -23.14% | $80.77K | vs AGL |
| SHCSotera Health Company | 15.91 | -1.85% | $4.54B | vs AGL |
| DVADaVita Inc. | 161.03 | +3.00% | $10.13B | vs AGL |
Indexes, lists and sector
agilon health inc. stock FAQ
What is agilon health inc.'s stock price today?
AGL last traded at $90.24 as of Nov 20, 4:00 PM EST, up 0.83% on the day. Prices are delayed at least 15 minutes.
Does agilon health inc. pay a dividend?
No. agilon health inc. does not currently pay a regular cash dividend.
Who is agilon health inc.'s CEO?
Mr. Timothy Patrick O'Rourke is the chief executive officer of agilon health inc., which has about 856 employees.
Has AGL ever split its stock?
Yes. The most recent AGL stock split was a 1-for-25 split on Mar 31, 2026.
What is the AGL 52-week high?
The 52-week high for AGL is $133.04 and the 52-week low is $7.48. The stock is currently 32.2% below its high.